{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T14:01:08Z","timestamp":1762783268950,"version":"3.41.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,20]]},"DOI":"10.7759\/cureus.86425","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T12:58:43Z","timestamp":1750424323000},"source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of Statins in Postmenopausal Osteoporosis: A Systematic Review and Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Pritam","family":"Biswas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukumar","family":"Thorenoor Kumaraswamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob","family":"Hilgers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-18-0056","article-title":"Therapy of endocrine disease: denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosis","volume":"179","author":"Anastasilakis AD","year":"2018","unstructured":"Anastasilakis AD, Polyzos SA, Makras P. Therapy of endocrine disease: denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosis. Eur J Endocrinol. 2018, 179:R31-45. 10.1530\/EJE-18-0056","journal-title":"Eur J Endocrinol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.69","article-title":"Postmenopausal osteoporosis","volume":"2","author":"Eastell R","year":"2016","unstructured":"Eastell R, O'Neill TW, Hofbauer LC, Langdahl B, Reid IR, Gold DT, Cummings SR. Postmenopausal osteoporosis. Nat Rev Dis Primers. 2016, 2:16069. 10.1038\/nrdp.2016.69","journal-title":"Nat Rev Dis Primers"},{"key":"ref3","article-title":"An Aging World: International Population Reports","author":"Kinsella K","year":"2009","unstructured":"Kinsella K, Wan H. An Aging World: International Population Reports . United States Census Bureau, Washington, DC; 2009."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/1060028014545038","article-title":"Association of statins and risk of fractures in a military health system: a propensity score-matched analysis","volume":"48","author":"Ward IM","year":"2014","unstructured":"Ward IM, Mortensen EM, Battafarano DF, Frei CR, Mansi I. Association of statins and risk of fractures in a military health system: a propensity score-matched analysis. Ann Pharmacother. 2014, 48:1406-14. 10.1177\/1060028014545038","journal-title":"Ann Pharmacother"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-016-3844-8","article-title":"Efficacy of statins for osteoporosis: a systematic review and meta-analysis","volume":"28","author":"An T","year":"2017","unstructured":"An T, Hao J, Sun S, Li R, Yang M, Cheng G, Zou M. Efficacy of statins for osteoporosis: a systematic review and meta-analysis. Osteoporos Int. 2017, 28:47-57. 10.1007\/s00198-016-3844-8","journal-title":"Osteoporos Int"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1126\/science.286.5446.1946","article-title":"Stimulation of bone formation in vitro and in rodents by statins","volume":"286","author":"Mundy G","year":"1999","unstructured":"Mundy G, Garrett R, Harris S, et al.. Stimulation of bone formation in vitro and in rodents by statins. Science. 1999, 286:1946-9. 10.1126\/science.286.5446.1946","journal-title":"Science"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)05917-0","article-title":"Inhibition of proinflammatory cytokine production by pravastatin","volume":"353","author":"Rosenson RS","year":"1999","unstructured":"Rosenson RS, Tangney CC, Casey LC. Inhibition of proinflammatory cytokine production by pravastatin. Lancet. 1999, 353:983-4. 10.1016\/S0140-6736(98)05917-0","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2015.07.022","article-title":"Potential mechanisms and applications of statins on osteogenesis: current modalities, conflicts and future directions","volume":"215","author":"Oryan A","year":"2015","unstructured":"Oryan A, Kamali A, Moshiri A. Potential mechanisms and applications of statins on osteogenesis: current modalities, conflicts and future directions. J Control Release. 2015, 215:12-24. 10.1016\/j.jconrel.2015.07.022","journal-title":"J Control Release"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1210\/er.2001-4002","article-title":"Meta-analyses of therapies for postmenopausal osteoporosis. IV. Meta-analysis of raloxifene for the prevention and treatment of postmenopausal osteoporosis","volume":"23","author":"Cranney A","year":"2002","unstructured":"Cranney A, Tugwell P, Zytaruk N, et al.. Meta-analyses of therapies for postmenopausal osteoporosis. IV. Meta-analysis of raloxifene for the prevention and treatment of postmenopausal osteoporosis. Endocr Rev. 2002, 23:524-8. 10.1210\/er.2001-4002","journal-title":"Endocr Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2007.02.019","article-title":"Effects of statins on bone mineral density: a meta-analysis of clinical studies","volume":"40","author":"Uzzan B","year":"2007","unstructured":"Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Effects of statins on bone mineral density: a meta-analysis of clinical studies. Bone. 2007, 40:1581-7. 10.1016\/j.bone.2007.02.019","journal-title":"Bone"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S145311","article-title":"High-potency statins but not all statins decrease the risk of new-onset osteoporotic fractures: a nationwide population-based longitudinal cohort study","volume":"10","author":"Lin TK","year":"2018","unstructured":"Lin TK, Liou YS, Lin CH, Chou P, Jong GP. High-potency statins but not all statins decrease the risk of new-onset osteoporotic fractures: a nationwide population-based longitudinal cohort study. Clin Epidemiol. 2018, 10:159-65. 10.2147\/CLEP.S145311","journal-title":"Clin Epidemiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000017476","article-title":"Case-control study examining the association between hip fracture risk and statins therapy in old people","volume":"98","author":"Cheng KC","year":"2019","unstructured":"Cheng KC, Liao KF, Lin CL, Lin CC, Lai SW. Case-control study examining the association between hip fracture risk and statins therapy in old people. Medicine (Baltimore). 2019, 98:e17476. 10.1097\/MD.0000000000017476","journal-title":"Medicine (Baltimore)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0196713","article-title":"Long-term effect of statins on the risk of new-onset osteoporosis: a nationwide population-based cohort study","volume":"13","author":"Lin TK","year":"2018","unstructured":"Lin TK, Chou P, Lin CH, Hung YJ, Jong GP. Long-term effect of statins on the risk of new-onset osteoporosis: a nationwide population-based cohort study. PLoS One. 2018, 13:e0196713. 10.1371\/journal.pone.0196713","journal-title":"PLoS One"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215714","article-title":"Diagnosis of osteoporosis in statin-treated patients is dose-dependent","volume":"78","author":"Leutner M","year":"2019","unstructured":"Leutner M, Matzhold C, Bellach L, et al.. Diagnosis of osteoporosis in statin-treated patients is dose-dependent. Ann Rheum Dis. 2019, 78:1706-11. 10.1136\/annrheumdis-2019-215714","journal-title":"Ann Rheum Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.164.2.146","article-title":"Use of statins and fracture: results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials","volume":"164","author":"Bauer DC","year":"2004","unstructured":"Bauer DC, Mundy GR, Jamal SA, et al.. Use of statins and fracture: results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials. Arch Intern Med. 2004, 164:146-52. 10.1001\/archinte.164.2.146","journal-title":"Arch Intern Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-004-1793-0","article-title":"Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: a meta-analysis","volume":"16","author":"Hatzigeorgiou C","year":"2005","unstructured":"Hatzigeorgiou C, Jackson JL. Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: a meta-analysis. Osteoporos Int. 2005, 16:990-8. 10.1007\/s00198-004-1793-0","journal-title":"Osteoporos Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6747469","article-title":"Meta-analysis of the efficacy and safety of alendronate combined with atorvastatin in the treatment of osteoporosis in diabetes mellitus","volume":"2022","author":"Xiong Z","year":"2022","unstructured":"Xiong Z, Yi P, Tang X, Shu L, Zhang C. Meta-analysis of the efficacy and safety of alendronate combined with atorvastatin in the treatment of osteoporosis in diabetes mellitus. Biomed Res Int. 2022, 2022:6747469. 10.1155\/2022\/6747469","journal-title":"Biomed Res Int"},{"key":"ref18","unstructured":"Review-writing software. RevMan| RevMan 5 | Cochrane. (2018). Accessed: January 25, 2025: http:\/\/community.cochrane.org\/tools\/review-production-tools\/revman-5."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins JP","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, et al.. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011, 343:d5928. 10.1136\/bmj.d5928","journal-title":"BMJ"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher D","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009, 6:e1000097. 10.1371\/journal.pmed.1000097","journal-title":"PLoS Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins D","year":"2004","unstructured":"Atkins D, Best D, Briss PA, et al.. Grading quality of evidence and strength of recommendations. BMJ. 2004, 328:1490. 10.1136\/bmj.328.7454.1490","journal-title":"BMJ"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-004-1598-1","article-title":"Age-dependent effects of atorvastatin on biochemical bone turnover markers: a randomized controlled trial in postmenopausal women","volume":"15","author":"Berthold HK","year":"2004","unstructured":"Berthold HK, Unverdorben S, Zittermann A, et al.. Age-dependent effects of atorvastatin on biochemical bone turnover markers: a randomized controlled trial in postmenopausal women. Osteoporos Int. 2004, 15:459-67. 10.1007\/s00198-004-1598-1","journal-title":"Osteoporos Int"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s001980170106","article-title":"The effect of fluvastatin on parameters of bone remodeling","volume":"12","author":"Bjarnason NH","year":"2001","unstructured":"Bjarnason NH, Riis BJ, Christiansen C. The effect of fluvastatin on parameters of bone remodeling. Osteoporos Int. 2001, 12:380-4. 10.1007\/s001980170106","journal-title":"Osteoporos Int"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1909","article-title":"Effects of atorvastatin on bone in postmenopausal women with dyslipidemia: a double-blind, placebo-controlled, dose-ranging trial","volume":"92","author":"Bone HG","year":"2007","unstructured":"Bone HG, Kiel DP, Lindsay RS, et al.. Effects of atorvastatin on bone in postmenopausal women with dyslipidemia: a double-blind, placebo-controlled, dose-ranging trial. J Clin Endocrinol Metab. 2007, 92:4671-7. 10.1210\/jc.2006-1909","journal-title":"J Clin Endocrinol Metab"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-3-7","article-title":"Effect of simvastatin on bone markers in osteopenic women: a placebo-controlled, dose-ranging trial [ISRCTN85429598]","volume":"3","author":"Hsia J","year":"2002","unstructured":"Hsia J, Morse M, Levin V. Effect of simvastatin on bone markers in osteopenic women: a placebo-controlled, dose-ranging trial [ISRCTN85429598]. BMC Musculoskelet Disord. 2002, 3:7. 10.1186\/1471-2474-3-7","journal-title":"BMC Musculoskelet Disord"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.040209","article-title":"Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women","volume":"19","author":"Rejnmark L","year":"2004","unstructured":"Rejnmark L, Buus NH, Vestergaard P, Heickendorff L, Andreasen F, Larsen ML, Mosekilde L. Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women. J Bone Miner Res. 2004, 19:737-44. 10.1359\/JBMR.040209","journal-title":"J Bone Miner Res"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2004.08.007","article-title":"Statins have additive effects to vertebral bone mineral density in combination with risedronate in hypercholesterolemic postmenopausal women","volume":"120","author":"Tanriverdi HA","year":"2005","unstructured":"Tanriverdi HA, Barut A, Sarikaya S. Statins have additive effects to vertebral bone mineral density in combination with risedronate in hypercholesterolemic postmenopausal women. Eur J Obstet Gynecol Reprod Biol. 2005, 120:63-8. 10.1016\/j.ejogrb.2004.08.007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2014.6388","article-title":"Statin therapy and risk of fracture: results from the JUPITER randomized clinical trial","volume":"175","author":"Pe\u00f1a JM","year":"2015","unstructured":"Pe\u00f1a JM, Aspberg S, MacFadyen J, Glynn RJ, Solomon DH, Ridker PM. Statin therapy and risk of fracture: results from the JUPITER randomized clinical trial. JAMA Intern Med. 2015, 175:171-7. 10.1001\/jamainternmed.2014.6388","journal-title":"JAMA Intern Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(00)04042-3","article-title":"Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial","volume":"357","author":"Reid IR","year":"2001","unstructured":"Reid IR, Hague W, Emberson J. Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Lancet. 2001, 357:509-12. 10.1016\/s0140-6736(00)04042-3","journal-title":"Lancet"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0376-2491.2013.29.017","article-title":"Effects of statins upon bone mineral density in postmenopausal women with hypercholesterolemia","volume":"93","author":"Zhao C","year":"2013","unstructured":"Zhao C, Bi Q, Hu J et al.. Effects of statins upon bone mineral density in postmenopausal women with hypercholesterolemia. Nat Med J China. 2013, 93:2309-11. 10.3760\/cma.j.issn.0376-2491.2013.29.017","journal-title":"Nat Med J China"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/375796-efficacy-of-statins-in-postmenopausal-osteoporosis-a-systematic-review-and-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T12:58:45Z","timestamp":1750424325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/375796-efficacy-of-statins-in-postmenopausal-osteoporosis-a-systematic-review-and-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.86425","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,20]]}}}